Janus Henderson Investors US’s Ionis Pharmaceuticals IONS Stock Holding History

Janus Henderson Investors US’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,100	Closed	-$292K	–	1179
2016 Q4	$292K	Sell	6,100 -6,700	-52%	-$265K	﹤0.01%	1161
2016 Q3	$469K	Sell	12,800 -477,900	-97%	-$15M	﹤0.01%	1121
2016 Q2	$11.4M	Buy	490,700 +198,400	+68%	+$6.4M	0.01%	651
2016 Q1	$11.8M	Buy	292,300 +265,400	+987%	+$10.8M	0.01%	643
2015 Q4	$1.67M	Sell	26,900 -55,000	-67%	-$2.97M	﹤0.01%	963
2015 Q3	$3.31M	Sell	81,900 -333,238	-80%	-$17.2M	﹤0.01%	885
2015 Q2	$23.9M	Buy	415,138 +336,238	+426%	+$21.4M	0.02%	577
2015 Q1	$5.02M	Buy	+78,900	New	+$5.35M	﹤0.01%	792

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Janus Henderson Investors US's IONS Position: Q1 2017 in Review

Janus Henderson Investors US sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 6,100 shares — an estimated $292K sold.

Janus Henderson Investors US first reported a position in IONS in Q1 2015 and held it in 8 quarters. The position peaked at $23.9M in Q2 2015. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

Janus Henderson Investors US reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
Janus Henderson Investors US sold 6,100 Ionis Pharmaceuticals shares in Q1 2017, an estimated $292K.
Janus Henderson Investors US first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 8 quarters.
Janus Henderson Investors US's Ionis Pharmaceuticals position peaked at $23.9M in Q2 2015.
270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.